It is a business outsourcing private limited company based in Bangalore, Karnataka, India, established in 2013.
2013 | Bangalore, Karnataka, India | ActiveShirdi Pharmaceutical Consultancy Private Limited, a active private limited company, was established on 23 May 2013 in Bangalore, Karnataka, India. Engaging in business & it consulting within the business outsourcing sector, it holds CIN: U85110KA2013PTC069267. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Narasimha Geetha Murthy (Director), Appanna Jayamma (Director), Parwathamma (Director). Past directors included Yergunta Chandranna Swetha. Its latest AGM occurred on 30 September 2019, with the balance sheet filed on 31 March 2019. It is based at No651,Nalme13Thcrosschandralayout1Ststage,1Stphase, Bangalore, Karnataka, 560079.
U85110KA2013PTC069267
069267
23 May 2013
₹0.50 M
₹0.10 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Shirdi Pharmaceutical Consultancy Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Narasimha Geetha Murthy | Director | 11 Aug 2014 | Current |
| Appanna Jayamma | Director | 11 Aug 2014 | Current |
| Parwathamma | Director | 11 Aug 2014 | Current |
| Yeraguntlu Rudranna Eswaramma | Director | 13 Jan 2014 | Current |
| Kattimane Tammanna Virupakshappa | Director | 13 Jan 2014 | Current |
| Ganesh Bhat | Director | 23 May 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 14 Mar 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Shirdi Pharmaceutical Consultancy Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 97.72% decrease. The company also saw a substantial fall in profitability, with a 496.02% decrease in profit. The company's net worth observed a substantial decline by a decrease of 89.09%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Shirdi Pharmaceutical Consultancy had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Shirdi Pharmaceutical Consultancy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Shirdi Pharmaceutical Consultancy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shirdi Pharmaceutical Consultancy's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Shirdi Pharmaceutical Consultancy Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records. was documented.
Shirdi Pharmaceutical Consultancy Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Bangalore. was recorded as a recent event.
The activity Narasimha Geetha Murthy was appointed as a Director was appointed as a Director on 11 Aug 2014 & has been associated with this company since 11 years 3 months . was completed.
The activity Appanna Jayamma was appointed as a Director was appointed as a Director on 11 Aug 2014 & has been associated with this company since 11 years 3 months . was completed.
The activity Parwathamma was appointed as a Director was appointed as a Director on 11 Aug 2014 & has been associated with this company since 11 years 3 months . was completed.
Progress on Yeraguntlu Rudranna Eswaramma was appointed as a Director was appointed as a Director on 13 Jan 2014 & has been associated with this company since 11 years 10 months . was documented.
The CIN of Shirdi Pharmaceutical Consultancy Private Limited is U85110KA2013PTC069267.
Shirdi Pharmaceutical Consultancy Private Limited is headquartered at No651,Nalme13Thcrosschandralayout1Ststage,1Stphase, Bangalore, Karnataka, 560079.
Shirdi Pharmaceutical Consultancy Private Limited was incorporated on 23 May 2013.
The current directors of Shirdi Pharmaceutical Consultancy Private Limited are
The primary industry of Shirdi Pharmaceutical Consultancy Private Limited is Business Outsourcing.
Shirdi Pharmaceutical Consultancy Private Limited is unlisted.
The authorized capital of Shirdi Pharmaceutical Consultancy Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.
The compliance status of Shirdi Pharmaceutical Consultancy Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX